However, the likelihood of a hip fracture risk reduction is enhanced by a significant ( P = 0.02) trend of reducing HR with duration of supplementation in the no personal supplements group and by nominally significant risk reductions over the entire follow-up period among adherent women, both in the overall trial cohort and in the no personal supplements subset (Table 6 ).
← all excerpts
Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study.
1
—
—